Literature DB >> 9874276

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.

Y Saeki1, T Ichikawa, A Saeki, E A Chiocca, K Tobler, M Ackermann, X O Breakefield, C Fraefel.   

Abstract

Herpes simplex virus type 1 (HSV-1)-based amplicon vectors contain only approximately 1% of the 152-kb HSV-1 genome, and consequently, replication and packaging into virions depends on helper functions. These helper functions have been provided conventionally by a helper virus, usually a replication-defective mutant of HSV-1, or more recently, by a set of five cosmids that overlap and represent the genome of HSV-1 deleted for DNA cleavage/packaging signals (pac). In the absence of pac signals, potential HSV-1 genomes that are reconstituted from the cosmids via homologous recombination are not packageable. The resulting amplicon stocks are, therefore, virtually free of contaminating helper virus. To simplify this packing system, the HSV-1 genome was cloned and maintained stably as a single-copy, F plasmid-based bacterial artificial chromosome in E. coli. Such a plasmid containing the HSV-1 genome deleted for the pac signals (fHSV delta pac) did not generate replication-competent progeny virus on transfection into mammalian cells, but rather, it was able to support the packaging of cotransfected amplicon DNA that contained a functional pac signal. The resulting amplicon vector stocks had titers of up to 10(7) transducing units per milliliter of culture medium and efficiently transduced neural cells in the rat brain, as well as hepatocytes in the rat. The capacity of generating infectious and replication-competent HSV-1 progeny following transfection into mammalian cells was restored after insertion of a pac signal into fHSV delta pac.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874276     DOI: 10.1089/hum.1998.9.18-2787

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  59 in total

1.  A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.

Authors:  G A Smith; L W Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Effects of mutations within the herpes simplex virus type 1 DNA encapsidation signal on packaging efficiency.

Authors:  P D Hodge; N D Stow
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  MRI of transgene expression: correlation to therapeutic gene expression.

Authors:  Tomotsugu Ichikawa; Dagmar Högemann; Yoshinaga Saeki; Edyta Tyminski; Kinya Terada; Ralph Weissleder; E Antonio Chiocca; James P Basilion
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 8.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 9.  Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents.

Authors:  Jacqueline N Parker; Xiaojia Zheng; William Luckett; James M Markert; Kevin A Cassady
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

10.  Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation.

Authors:  Anne M Paredes; Dong Yu
Journal:  Curr Protoc Microbiol       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.